PCM
PLX icon

Penserra Capital Management’s Protalix BioTherapeutics PLX Stock Holding History

Penserra Capital Management’s Portfolio PLX Stock Details PLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,680
Closed -$5.38K – 1006
2016
Q1 		$5.38K Buy
1,680
+534
+47% +$1.71K 0.52% 42
2015
Q4 		$12K Buy
+1,146
New +$12K ﹤0.01% 493